Filing Flows › Mimedx Group (MDXG) › Guidance history
Mimedx Group (MDXG) guidance history: what it guided and what it reported
Mimedx Group gave guidance in 3 earnings releases on file since Apr 29, 2026. Its releases raised guidance 0 times and lowered it twice.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $260M–$290M (Apr 29, 2026) → reaffirmed $260M–$290M (Jul 29, 2026) → lowered $250M–$260M (Oct 28, 2026) | — | to be reported | — |
Adjusted EBITDA margin
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 20.0% (Apr 29, 2026) → reaffirmed 20.0% (Jul 29, 2026) → reaffirmed 20.0% (Oct 28, 2026) | — | to be reported | — |
The latest quarter
Mimedx Group, Q3 2026: revenue $62.3M (-45% year over year), operating margin -18.8%, net loss $8.7M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.
Questions
Does Mimedx Group beat its guidance?
Mimedx Group gave guidance in 3 earnings releases on file since Apr 29, 2026. Its releases raised guidance 0 times and lowered it twice.
How often does Mimedx Group raise guidance?
Its earnings releases raised guidance 0 times and lowered it twice since Apr 29, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.